LOXL1 and neoplasm: In detail, we exposed mice (45 or 33 days after injection with U87-Vec or U87-LOXL1 cells, respectively) to IR or control treatment and found that mice injected with U87-Vec cells showed dramatically decreased tumor size, while the tumor size was barely changed in mice injected with U87-LOXL1 cells (Fig. 2h).